Xencor, Inc. (XNCR)
24.63
+0.13
(+0.53%)
USD |
NASDAQ |
Oct 09, 16:00
24.59
-0.04
(-0.16%)
After-Hours: 20:00
Xencor Free Cash Flow (Quarterly) : -56.20M for June 30, 2026
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -56.20M |
| March 31, 2026 | -68.24M |
| December 31, 2025 | -52.85M |
| September 30, 2025 | -31.00M |
| June 30, 2025 | -36.75M |
| March 31, 2025 | -17.66M |
| December 31, 2024 | -52.52M |
| September 30, 2024 | -28.14M |
| June 30, 2024 | -68.98M |
| March 31, 2024 | -56.32M |
| December 31, 2023 | 179.50M |
| September 30, 2023 | -30.70M |
| June 30, 2023 | -43.14M |
| March 31, 2023 | -41.80M |
| December 31, 2022 | -35.33M |
| September 30, 2022 | -16.03M |
| June 30, 2022 | 29.62M |
| March 31, 2022 | 2.82M |
| December 31, 2021 | 55.14M |
| September 30, 2021 | -42.79M |
| June 30, 2021 | -13.19M |
| March 31, 2021 | -31.99M |
| December 31, 2020 | 12.85M |
| September 30, 2020 | -9.237M |
| June 30, 2020 | -29.23M |
| Date | Value |
|---|---|
| March 31, 2020 | 6.849M |
| December 31, 2019 | -23.24M |
| September 30, 2019 | -9.821M |
| June 30, 2019 | 106.59M |
| March 31, 2019 | -20.19M |
| December 31, 2018 | -20.20M |
| September 30, 2018 | -11.74M |
| June 30, 2018 | -29.98M |
| March 31, 2018 | -26.98M |
| December 31, 2017 | -8.592M |
| September 30, 2017 | -6.513M |
| June 30, 2017 | -14.03M |
| March 31, 2017 | -11.74M |
| December 31, 2016 | -16.36M |
| September 30, 2016 | 132.89M |
| June 30, 2016 | -9.963M |
| March 31, 2016 | -14.96M |
| December 31, 2015 | -4.576M |
| September 30, 2015 | 38.61M |
| June 30, 2015 | -7.80M |
| March 31, 2015 | -3.239M |
| December 31, 2014 | -6.452M |
| September 30, 2014 | -5.293M |
| June 30, 2014 | -6.45M |
| March 31, 2014 | -5.441M |
Free Cash Flow Definition
Free Cash Flow is the cash a company has left after paying for its day-to-day operations and investing in its physical assets, such as buildings, equipment and technology. The company can use that cash however it chooses: paying dividends, buying back shares, paying down debt, making acquisitions or keeping it for future growth.
Free Cash Flow (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow (Quarterly) Benchmarks
| Ironwood Pharmaceuticals, Inc. | 58.28M |
| UroGen Pharma Ltd. | -35.08M |
| MeiraGTx Holdings Plc | -38.87M |
| IDEAYA Biosciences, Inc. | -89.08M |
| Iovance Biotherapeutics, Inc. | -66.28M |